TABLE 3.
Postdischarge Characteristics in Patients with 6-Month Follow-up by Receipt of PCE
| Visit Variables, N = 344 Admissions | Received Systemic Corticosteroid Within 14 Days of Discharge (PCE-C) | Received Systemic Bronchodilator Within 30 Days of Discharge (PCE-D) | ||||
|---|---|---|---|---|---|---|
|
Yes
n = 230 (67%) |
No
n = 114 (33%) |
P Value |
Yes
n = 274 (80%) |
No
n = 70 (20%) |
P Value | |
| Readmissions | ||||||
| All-cause | 0.77 (1.38) | 0.84 (1.13) | 0.576 | 0.74 (1.25) | 1.01 (1.47) | 0.098 |
| COPD-related | 0.22 (0.59) | 0.19 (0.55) | 0.592 | 0.23 (0.62) | 0.13 (0.34) | 0.055 |
| Readmission costs, $ | ||||||
| All-cause | 5,161 (22,825) | 4,114 (8,590) | 0.522 | 611 (1,840) | 382 (1,574) | 0.343 |
| COPD-related | 602 (1,863) | 488 (1,629) | 0.566 | 5,126 (21,296) | 3,631 (8,537) | 0.320 |
| ≥ 1 all-cause readmission | ||||||
| Yes | 101 (65%) [44%] | 54 (35%) [47%] | 0.544 | 118 (76%) [43%] | 37 (24%) [53%] | 0.142 |
| No | 129 (68%) [56%] | 60 (32%) [53%] | 156 (83%) [57%] | 33 (17%) [47%] | ||
| ≥ 1 COPD-related readmission | ||||||
| Yes | 42 (70%) [18%] | 18 (30%) [16%] | 0.570 | 50 (83%) [18%] | 10 (17%) [14%] | 0.436 |
| No | 188 (66%) [82%] | 96 (34%) [84%] | 224 (79%) [82%] | 60 (21%) [86%] | ||
Note: Expressed as mean (SD) for continuous variables or count (Row %) [Column %] for categorical variables.
COPD = chronic obstructive pulmonary disease; PCE = pharmacotherapy management of COPD exacerbation; SD = standard deviation.